NASDAQ:CCCC

C4 Therapeutics Earning Date

USA |NASDAQ |USD

CCCC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 12, 2021 (est) Sep 30, 2021 - $-0.51 $-0.63
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 12, 2021 (est) Sep 30, 2021 - $9.78M $8.45M

C4 Therapeutics's next estimated earnings date (based on same quarter last year's date) is Nov 12, 2021 for the fiscal quarter ending Sep 30, 2021.

CCCC Earnings Date & History Chart

CCCC Earnings & Revenue Forecast

CCCC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.68 $-0.79 $-0.61
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-2.28 $-2.55 $-2.15
Dec 2022 5 $-2.45 $-3.06 $-2.06

CCCC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.68 $-0.66 $-0.66
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.28 $-2.25 $-2.25
Dec 2022 0 / 0 $-2.30 $-2.23 $-2.23

CCCC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $6.24M $2.91M $8.97M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $31.13M $27.20M $35.33M
Dec 2022 5 $29.45M $19.54M $40.00M

CCCC Earnings Date & Revenue History

CCCC Earnings History

|
Show More
Show More

CCCC Revenue History

|
Show More
Show More

C4 Therapeutics Next Earnings Date & Report

CCCC Aug 2021 (FQ) Earnings Date & Report Preview

CCCC's next estimated earnings date (based on same quarter last year's report date) is Nov 12, 2021 for the fiscal quarter ending Sep 30, 2021.

C4 Therapeutics Previous Earnings Dates & Reports

CCCC Previous Earnings Date & Report Recap: Jun 2021 (FQ)

C4 Therapeutics's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.

CCCC's earnings per share (EPS) was $-0.51, beating the consensus analysts forecast of $-0.56 by 8.11%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 4.08%.

Revenues were $9.78M, better than the forecast of $6.02M by 62.48%, up by 31.71% from the previous quarter , and up by 1.15% from the same period last year.

The company reported a net income of $-22.58M.

Free cash flow for the quarter was $-18.75M , compared to $-25.36M last quarter and $-14.48M a year before.

CCCC ended the quarter with $22.77M in total debt, a decrease of -0.35% compared to the previous quarter, and a decrease of -79.96% compared to the same quarter a year before.

CCCC Previous Earnings Date & Report Recap: Dec 2020 (FY)

C4 Therapeutics's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

CCCC's earnings per share (EPS) was $-0.89.

Revenues were $33.20M, better than the forecast of $33.20M by 0.00%, and up by 55.25% from previous year's revenue.

The company reported a net income of $-66.33M.

C4 Therapeutics reported a free cash flow of $-67.90M for its fiscal year, compared to $54.27M a year ago.

The company ended the fiscal year with $11.09M in total debt, a decrease of -19.31% compared to the previous year.